Oric Pharmaceuticals

$21.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.92 (+4.53%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ORIC and other stocks, options, and ETFs commission-free!

About ORIC

Oric Pharmaceuticals, Inc. Common Stock, also called Oric Pharmaceuticals, is a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. Read More It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA. The listed name for ORIC is Oric Pharmaceuticals, Inc. Common Stock.

Employees
57
Headquarters
South San Francisco, California
Founded
2014
Market Cap
636.27M
Price-Earnings Ratio
Dividend Yield
Average Volume
151.74K
High Today
$21.52
Low Today
$20.14
Open Price
$21.40
Volume
136.57K
52 Week High
$40.67
52 Week Low
$18.60

Collections

ORIC Earnings

-$4.46
-$2.97
-$1.49
$0.00
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 4, After Hours

You May Also Like